glp 1 agonist therapy New GLP-1 Guidelines for Type 2 Diabetes in 2025 GLP-1 Receptor Agonists: From Diabetes
Description
2016;310(1):G26-33
Liddle C, Goodwin BJ, George J, Tapner M, Farrell GC
Mechanistic studies confirm that GLP-1 receptor activation in the gastric fundus and pylorus reduces gastric motility and delays emptying
Reduced HRV during the early treatment phase is expected and typically normalizes during the adaptation phase
Dig Dis Sci 1998
Glucagon-like peptide-1 receptor agonists and gastric emptying time: a systematic review and meta-analysis of prospective studies
